BPC-157 Protects Against NSAID Gut Damage and Leaky Gut Syndrome
BPC-157 rescues NSAID-induced gastrointestinal damage by stabilizing intestinal permeability, protecting endothelium, and exerting cytoprotective effects across multiple organ systems.
Quick Facts
What This Study Found
BPC-157 rescues NSAID-induced gut damage by stabilizing intestinal permeability and providing cytoprotection across the GI tract and other organs, potentially addressing leaky gut syndrome.
Key Numbers
BPC-157 counteracts NSAIDs, alcohol, bile acids, stress on gut permeability; protective in stomach, intestine, skin, liver, pancreas, heart, brain
How They Did This
Narrative review compiling evidence for BPC-157 cytoprotective and organoprotective effects against NSAID-induced damage, intestinal permeability changes, and endothelial injury.
Why This Research Matters
NSAID use is widespread and GI side effects affect millions. A peptide that specifically protects the gut lining from NSAID damage could prevent a major source of medication-related morbidity.
The Bigger Picture
BPC-157's broad cytoprotective profile — from stomach to brain — suggests it activates fundamental cell survival pathways rather than organ-specific mechanisms, positioning it as a systemic protectant.
What This Study Doesn't Tell Us
Review without new experimental data; most evidence from animal studies; human clinical trials for NSAID gastroprotection are lacking; mechanisms not fully elucidated.
Questions This Raises
- ?Can BPC-157 be co-administered with NSAIDs to prevent gut damage in clinical practice?
- ?How does BPC-157 compare to proton pump inhibitors for NSAID gastroprotection?
- ?What is the molecular mechanism by which BPC-157 stabilizes intestinal tight junctions?
Trust & Context
- Key Stat:
- Multi-organ cytoprotection BPC-157 protects against NSAID damage in stomach, intestines, liver, pancreas, heart, and brain
- Evidence Grade:
- Comprehensive review of preclinical evidence showing consistent cytoprotective effects, but human clinical data specifically for NSAID gastroprotection is absent.
- Study Age:
- Published in 2020; BPC-157 remains widely studied preclinically but lacks Phase III clinical trials for any indication.
- Original Title:
- BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing Cytoprotection.
- Published In:
- Current pharmaceutical design, 26(25), 2971-2981 (2020)
- Authors:
- Park, Jong M, Lee, Ho J, Sikiric, Predrag(44), Hahm, Ki B
- Database ID:
- RPEP-05054
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Can BPC-157 protect against ibuprofen stomach damage?
Preclinical evidence shows BPC-157 stabilizes gut permeability and protects the gastrointestinal lining from NSAID damage, though human clinical trials have not yet been conducted.
What is leaky gut and can BPC-157 help?
Leaky gut occurs when intestinal permeability increases, allowing harmful substances to pass through. BPC-157 has been shown to stabilize intestinal permeability in preclinical studies, potentially addressing this condition.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05054APA
Park, Jong M; Lee, Ho J; Sikiric, Predrag; Hahm, Ki B. (2020). BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing Cytoprotection.. Current pharmaceutical design, 26(25), 2971-2981. https://doi.org/10.2174/1381612826666200523180301
MLA
Park, Jong M, et al. "BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing Cytoprotection.." Current pharmaceutical design, 2020. https://doi.org/10.2174/1381612826666200523180301
RethinkPeptides
RethinkPeptides Research Database. "BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestina..." RPEP-05054. Retrieved from https://rethinkpeptides.com/research/park-2020-bpc-157-rescued-nsaidcytotoxicity
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.